GTBP GT Biopharma
- 3.5300
- -0.1500-4.08%
- 3.5300
- 0.00000.00%
GT Biopharma News
CureVac, Oragenics, IGM Biosciences Among Healthcare Movers
PLAB, MMAT and HBM Among Pre-market Losers
Biodexa BDRX Data; GT Biopharma GTBP Offering
Top Midday Decliners
GT Biopharma (GTBP) said Tuesday it priced a registered direct offering of 740,000 shares at $4.35 per share to raise about $3.2 million for general corporate purposes. It will also issue warrants in
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersBiodexa Pharmaceuticals (NASDAQ:BDRX) stock increased by 84.3% to $2.34 during Tuesday's regular session. The market value of their outstanding shares is at $10.2 million. Genelux (NASDAQ:GNLX)
GT Biopharma Shares Are Trading Lower After the Company Announced a $3.2 Million Registered Direct Offering of 740,000 Shares of Common Stock at $4.35 per Share.
GT Biopharma Shares Are Trading Lower After the Company Announced a $3.2 Million Registered Direct Offering of 740,000 Shares of Common Stock at $4.35 per Share.
What's Going On With GT Biopharma Stock Tuesday?
GT Biopharma (NASDAQ:GTBP) shares rose Tuesday morning before pulling back and turning negative after the company announced a direct offering.The Details: GT Biopharma entered into a definitive securi
GT Biopharma Stock Falls on $3.2M Equity Raise
GT Biopharma Shares Rise 16% After Direct Offering Prices
By Chris Wack GT Biopharma shares were up 16% at $9.06 after the company entered into a securities purchase agreement for the purchase and sale of 740,000 shares at $4.35 a share in a registered dire
Tandem Diabetes Care, Guardion Health, GT Biopharma Among Healthcare Movers
GT Biopharma Shares Halted On Circuit Breaker To The Upside, Stock Now Up 3.97%
GT Biopharma Shares Halted On Circuit Breaker To The Upside, Stock Now Up 3.97%
GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
BRISBANE, CALIFORNIA, May 21, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ:GTBP) (the "Company"), today announced that it has entered into a definitive securities purchase agreements for the purchase and sale of
12 Health Care Stocks Moving In Monday's After-Market Session
GainersLarimar Therapeutics (NASDAQ:LRMR) stock increased by 23.6% to $8.99 during Monday's after-market session. The company's market cap stands at $573.5 million. GT Biopharma (NASDAQ:GTBP) stock ro
GT Biopharma GTBP Earnings; Jaguar JAGX Reverse Stock Split
What's Going On With GT Biopharma Stock?
GT Biopharma, Inc. (NASDAQ:GTBP) shares are racing higher Monday on heavy trading volume. Here's a look at what's going on. What To Know:GT Biopharma shares are moving on heavy trading volume despite
Trending Stocks Today: MultiMetaVerse Soars 136.96%
May 20th - US stocks trending in regular trading hours.Gainers: $MultiMetaVerse(MMV.US)$ shoots up 136.96% to $1.4 with a turnover of $192.18 million. $GT Biopharma(GTBP.US)$ surges 150.32% to $7.81 w
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI) fell sharply during Monday's session after the company priced a $1.7 million public offering of 8.5 million shares of common stock at $0.20 per share.
SCPX, XTIA and CRVO Among Mid-day Movers
Why Is GT Biopharma Stock Surging 125?
PTC Therapeutics, Oragenics, GT Biopharma Among Healthcare Movers
Analysis
Price Target
No Data
